|
BMS-986453 Clinical Trials
2 actively recruiting trials across 1 location
Birmingham, Alabama2 trials
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
University of Alabama at Birmingham
Phase 1
Study of BMS-986453 in Newly Diagnosed Multiple Myeloma
University of Alabama at Birmingham
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.